Human MIA PaCa-2 is a human pancreatic cancer cell line, established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. The cells exhibit CK5.6, AE1/AE3, E-cadherin, vimentin, chromogranin A, synaptophysin, SSTR2, and NTR1, but not CD56. It is widely used in pancreatic cancer research and therapy development.
This GFP / human MIA PaCa-2 cell line expresses the enhance GFP fluorescent marker. GFP was expressed under the constitutive EF1a Promoter. Cell line carries the Puromycin resistance.
The following expression cassette was integrated into the cell line’s genome.
Each cell showed GFP fluorescent signal. see a sample image below:
Sold at: 1 vial x (2 x 106 cells)/vial, see details in Product Manual.